Hsiao S.-H.TZUNG-JENG HWANGFANG-JU LINSheu J.-J.Wu C.-H.2021-07-062021-07-062021256196https://scholars.lib.ntu.edu.tw/handle/123456789/569579Objective: To evaluate the association between the use of cholinesterase inhibitors (ChEIs) and incident cardiovascular events (CVEs) among older patients with Alzheimer disease (AD). Patients and Methods: This retrospective cohort study was conducted wit[SDGs]SDG3antidepressant agent; antidiabetic agent; antihypertensive agent; antilipemic agent; antiparkinson agent; benzodiazepine derivative; cholinesterase inhibitor; donepezil; galantamine; neuroleptic agent; nonsteroid antiinflammatory agent; rivastigmine; cholThe Association Between the Use of Cholinesterase Inhibitors and Cardiovascular Events Among Older Patients With Alzheimer Diseaseconference paper10.1016/j.mayocp.2020.05.048335492562-s2.0-85100371130